David Mehalick

Overview

David Mehalick received an average of $313K in total compensation, including $288K in salary, at Coeptis Therapeutics Holdings from 2021 to 2023.

Source: SEC filings on November 14, 2024 and November 17, 2023.

Related executives

We found four more executives who work or worked at Coeptis Therapeutics Holdings.

Daniel Yerace

Coeptis Therapeutics Holdings

Vice President of Operations

Colleen Delaney

Coeptis Therapeutics Holdings

Chief Financial Officer

Brian Cogley

Coeptis Therapeutics Holdings

Chief Financial Officer

Christine Sheehy

Coeptis Therapeutics Holdings

Chief Financial Officer

News

You may also like